 The aim of the study is to compare, in real life, the risk benefit including both major bleeding and thrombotic events TE and death from any cause associated with direct oral anticoagulants DOA and with anti vitamin K VKA in older adults 80 years suffering from non valvular atrial fibrillation and living in community or nursing home settings. 